Free · No account

Create your own personal news briefing

A daily PDF of the news that moves your tickers — summaries and market impact, delivered an hour before the open.

Zacks Investment Research

05 Aug 2026, 00:31 UTC · 1h ago

Compared to Estimates, Chemours (CC) Q2 Earnings: A Look at Key Metrics

NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims

3 claims · each scored for market impact

What matters in this story

1
Chemours reported quarterly revenue of $1.59 billion, missing the Zacks Consensus Estimate of $1.67 billion by 4.97%. — A meaningful revenue miss relative to analyst expectations typically triggers negative price action.
-0.40
2
Chemours' quarterly EPS of $0.42 was lower than the $0.58 reported a year ago and slightly missed the consensus estimate of $0.43. — Declining year-over-year profitability and a miss on earnings expectations signal weakening fundamental health.
-0.30
3
Chemours' revenue for the quarter ended June 2026 declined by 1.5% year-over-year. — A decline in top-line growth suggests slowing demand or pricing pressure in the company's markets.
-0.20

Which stocks this story touches